Biochemical and Biophysical Research Communications
Volume 263, Issue 3, 5 October 1999, Pages 825-831
Regular ArticlePyridinylimidazole Compound SB 203580 Inhibits the Activity but Not the Activation of p38 Mitogen-Activated Protein Kinase☆
References (42)
Cell
(1995)- et al.
J. Biol. Chem.
(1995) - et al.
J. Biol. Chem.
(1996) - et al.
Cell
(1994) - et al.
J. Biol. Chem.
(1996) - et al.
J. Biol. Chem.
(1996) - et al.
J. Biol. Chem.
(1998) - et al.
Cell
(1994) - et al.
J. Biol. Chem.
(1995) - et al.
Biochem. Biophys. Res. Commun.
(1997)
Pharmacol. Ther.
(1999)
J. Biol. Chem.
(1997)
J. Biol. Chem.
(1996)
J. Biol. Chem.
(1996)
J. Biol. Chem.
(1998)
J. Biol. Chem.
(1996)
J. Biol. Chem.
(1996)
Chem. Biol.
(1997)
Structure
(1998)
J. Biol. Chem.
(1999)
Cited by (240)
Inhibiting O-GlcNAcylation impacts p38 and Erk1/2 signaling and perturbs cardiomyocyte hypertrophy
2023, Journal of Biological ChemistryMechanically reinforced injectable bioactive nanocomposite hydrogels for in-situ bone regeneration
2022, Chemical Engineering JournalThe p38 MAPK/snail signaling axis participates in cadmium-induced lung cancer cell migration and invasiveness
2024, Environmental Science and Pollution Research
- ☆
Abbreviations used: ERK; extracellular signal regulated kinase, MAPK; mitogen-activated protein kinase, MAPKAP K2; MAPK-activated protein kinase 2, MKK; MAP kinase kinase, ATF2; activating transcription factor 2, GST; glutathione S-transferase, TNF; tumor necrosis factor, IL-1; interleukin-1, LPS; lipopolysaccharide, MBP; myelin basic protein, SDS; sodium dodecyl sulfate, PAGE; polyacrylamide gel electrophoresis
- 1
To whom correspondence should be addressed at Department of Bone and Cartilage Biology, UW 2109, SmithKline Beecham Pharmaceuticals, P.O. Box 1539, King of Prussia, PA 19406-0939. Fax: 610-270-5598. E-mail: [email protected].
Copyright © 1999 Academic Press. All rights reserved.